Home
NewsNewsIVF bills can hit $30,000, creating major financial barriers for families. The HOPE with Fertility Services Act aims to mandate insurance coverage for infertility diagnosis, treatment, and preservation, potentially benefiting 133 million Americans while addressing affordability and expanding access to essential reproductive healthcare services across the United States.
In a landmark effort to modernize reproductive healthcare and support American families, a bipartisan coalition of lawmakers on Capitol Hill recently introduced the "Helping to Optimize Patients’ Experience with Fertility Services Act," widely referred to as the HOPE with Fertility Services Act. This legislative initiative, introduced on Thursday, March 26, 2026, seeks to drastically lower the financial hurdles associated with infertility treatment and fertility preservation, addressing the stark reality that IVF bills can hit $30,000.
The legislation was spearheaded by U.S. Representatives Debbie Wasserman Schultz (D-FL) and Zach Nunn (R-IA). They were joined by a robust group of co-leads, including Representatives Chrissy Houlahan (D-PA), Nicole Malliotakis (R-NY), Donald Norcross (D-NJ), and Laurel Lee (R-FL). The bill targets a critical gap in the current healthcare system: while many insurance plans cover prenatal and birth-related services, they often exclude the very treatments required to achieve pregnancy.
If enacted into law, the HOPE with Fertility Services Act would require all group health plans that provide coverage for obstetrical services to also include comprehensive benefits for infertility diagnosis and treatment, as well as standard fertility preservation services. Supporters of the bill emphasise that this measure is essential to closing long-standing insurance loopholes. Currently, these gaps force many prospective parents to pay for their medical care entirely out of pocket, a burden that is often insurmountable given that IVF bills can hit $30,000.
The scope of the bill is inclusive, designed to support a wide range of patients. This includes individuals diagnosed with specific medical conditions that prevent conception or the ability to carry a pregnancy to term, as well as those suffering from unexplained infertility. Crucially, the legislation also covers patients whose future fertility is threatened by necessary medical interventions, such as chemotherapy, radiation, surgery, or other invasive procedures.
Representative Debbie Wasserman Schultz, a breast cancer survivor and carrier of the BRCA gene mutation, shared her personal journey of conceiving twins through in vitro fertilization. She highlighted that fertility services are not just about family building but are often a medical necessity to prevent passing on genetic diseases. “Infertility impacts millions and doesn’t discriminate. It can affect anyone who wants to start or grow a family,” Wasserman Schultz stated, emphasizing that these services are currently prohibitively expensive for most people.
Co-sponsor Representative Zach Nunn, a father of six, framed the bill as a matter of fundamental American values. “Starting a family is one of the biggest dreams couples have, and no one should be denied that opportunity because of infertility, cancer treatments, or cost. This isn’t a Republican or Democrat idea — it’s an American one,” Nunn said.
The financial strain on American families was a recurring theme among the bill's backers. Representative Donald Norcross pointed out that a single cycle of IVF typically ranges from $15,000 to $30,000. He argued that because most insurance plans are not currently required to cover these costs, the HOPE with Fertility Services Act is vital to making family-building a reality for millions. Indeed, without such mandates, families are left to struggle alone when IVF bills can hit $30,000.
Advocacy groups and medical professionals have signalled strong support for the legislation. Danielle Melfi, CEO of RESOLVE: The National Infertility and Family Building Association, noted that infertility affects one in six people. She estimated that the bill could expand insurance coverage to approximately 133 million Americans who are currently enrolled in employer-sponsored health plans governed by the Employee Retirement Income Security Act (ERISA).
Medical experts warn that the lack of coverage often leads to delayed or even riskier medical treatments as patients try to cut costs. Dr. Valerie Lynn Baker, a reproductive endocrinologist and board member of the American Society for Reproductive Medicine (ASRM), observed that doctors are frequently unable to treat diagnosed conditions simply because patients cannot afford the care. “Other diseases are not approached this way,” she remarked, comparing infertility to other medical conditions that receive standard coverage.
Sean Tipton, ASRM’s chief advocacy and policy officer, further noted that the World Health Organization recognises infertility as a disease. “Access to care should never depend on a person’s ability to pay,” Tipton asserted, reinforcing the bill's goal of making fertility care an essential health benefit rather than a luxury.
The bill has garnered endorsements from prominent organisations, including ASRM, RESOLVE, the Tzedek Association, and Americans for IVF. The growing list of cosponsors reflects a broad geographic and political consensus, including Representatives Pat Ryan (D-NY), Dan Goldman (D-NY), Mike Lawler (R-NY), Young Kim (R-CA), Derrick Van Orden (R-WI), Brian Fitzpatrick (R-PA), and Greg Landsman (D-OH).
Representative Laurel Lee summarised the sentiment of the coalition, describing infertility as a deeply personal issue that transcends income or background. “Strong families are the foundation of a strong nation, and this bill is an investment in the future of our country,” Lee said. By ensuring that health insurance covers these essential services, lawmakers hope to provide a path forward for all Americans wishing to start a family, regardless of the fact that IVF bills can hit $30,000 in the current market.
A new Ipsos survey commissioned by Fertility Matters Canada finds 49% of Canadians with an opinion support a national baseline for IVF funding support, with backing rising to 59% among those aged 18–34. One in eight Canadians say cost has already forced them or someone close to delay or abandon fertility treatment.
Alpha Controls & Instrumentation Inc. has been selected by FertiTech Canada Inc. as its third-party calibration partner for Nilotech temperature probes. The partnership channels Canadian IVF laboratories and fertility clinics using Nilotech equipment to Alpha Controls for professional, accredited calibration services, while FertiTech continues to handle equipment supply and gas sensor calibration.
In the UK, a Ten Minute Rule Bill has been introduced in the Commons to create a legal right to paid time off for fertility treatment, aiming to standardize access to time‑sensitive appointments and reduce reliance on employer discretion. The proposal seeks House permission to proceed and spotlights workplace rights during Fertility Awareness Week.
Columbia University Fertility Center has achieved the first confirmed pregnancy using an AI-guided sperm recovery method in a man with azoospermia, as detailed in The Lancet. The STAR system combined advanced imaging, microfluidics, and robotics to retrieve two viable sperm, enabling embryo creation after prior failed surgical and manual attempts.
British Columbia's free IVF program exhausts 2025 funding within months of launch. At least one approved clinic stops accepting new applications. Applicants face aging-out risks and must wait until spring 2026 for next funding allocation.
Singapore’s MOH approves 13 additional genetic conditions for testing before embryos are implanted during IVF, enhancing reproductive genetic screening options.
National Health Service-funded IVF in England varies across regions in terms of access, cycle definitions, and eligibility. While Integrated Care Boards follow NICE guidelines, local implementation differs to meet specific population needs. Current policy reviews aim to enhance consistency and ensure continued access to fertility services across England.
